{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:20:26Z","timestamp":1777562426119,"version":"3.51.4"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1097\/mph.0b013e3182677f35","type":"journal-article","created":{"date-parts":[[2012,12,18]],"date-time":"2012-12-18T09:40:34Z","timestamp":1355823634000},"page":"76-80","source":"Crossref","is-referenced-by-count":14,"title":["Risk Factor Analysis of Bloodstream Infection in Pediatric Patients After Hematopoietic Stem Cell Transplantation"],"prefix":"10.1097","volume":"35","author":[{"given":"Takeo","family":"Sarashina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Iguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Okubo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naohisa","family":"Toriumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirozumi","family":"Sano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryoji","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-14-20210227","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/sj.bmt.1701562","article-title":"BSIs can develop late(after day 100)andor in the absence of neutropenia in children receiving allogeneic bone marrow transplantation.","volume":"23","author":"Romano","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"R3-14-20210227","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3109\/08880019709041593","article-title":"Febrile complications in the first 100 days after bone marrow transplantation in children: a single centers experience.","volume":"14","author":"DellOrto","year":"1997","journal-title":"Pediatr Hematol Oncol"},{"key":"R5-14-20210227","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/pbc.20277","article-title":"Early bacteremia in pediatric hematopoietic stem cell transplant patients on oral antibiotic prophylaxis.","volume":"45","author":"Kersun","year":"2005","journal-title":"Pediatr Blood Cancer"},{"key":"R6-14-20210227","first-page":"193","article-title":"Infectious complications in leukemic patients.","volume":"19","author":"Bodey","year":"1982","journal-title":"Semin Hematol"},{"key":"R7-14-20210227","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-2141.1986.tb07527.x","article-title":"Infective complications of aplastic anemia.","volume":"63","author":"Keidan","year":"1986","journal-title":"Br J Haematol"},{"key":"R8-14-20210227","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1086\/339215","article-title":"2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer.","volume":"34","author":"Hughes","year":"2002","journal-title":"Clin Infect Dis"},{"key":"R9-14-20210227","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/sj.bmt.1705164","article-title":"Adenovirus infection rates in pediatric recipients of alternate donor allogeneic bone marrow transplants receiving either antithymocyte globulin (ATG) or alemtuzumab (Campath).","volume":"36","author":"Myers","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"R10-14-20210227","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1399-3062.2005.00088.x","article-title":"Pre-and post-engraftment bloodstream rates and associated mortality in allogeneic hematopoietic stem cell transplant recipients.","volume":"7","author":"Almyroudis","year":"2005","journal-title":"Transpl Infect Dis"},{"key":"R11-14-20210227","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/sj.bmt.1705921","article-title":"Incidence of bacteremias and invasive mycoses in children undergoing allogeneic hematopoietic stem cell transplantation: single center experience.","volume":"41","author":"Castagnola","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"R12-14-20210227","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/sj.bmt.1705690","article-title":"BSI after hematopoietic stem cell transplantation is associated with increased mortality.","volume":"40","author":"Poutsiaka","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"R13-14-20210227","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1053\/bbmt.2002.v8.pm12374456","article-title":"Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: a matched control study.","volume":"8","author":"Junghanss","year":"2002","journal-title":"Biol Blood Marrow Transplant"},{"key":"R14-14-20210227","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1182\/blood.V84.4.1328.1328","article-title":"Increased risk of infection in marrow transplant patients receiving methylprednisolone for graft-versus-host disease prevention.","volume":"84","author":"Sayer","year":"1994","journal-title":"Blood"},{"key":"R15-14-20210227","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1038\/sj.bmt.1701246","article-title":"Unique risk factors for bacteremia in allogeneic bone marrow transplant recipients before and after engraftment.","volume":"21","author":"Yuen","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"R16-14-20210227","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s00277-004-0909-0","article-title":"Bacterial and fungal bloodstream isolates from 796 hematopoietic stem cell transplant recipients between 1991 and 2000.","volume":"84","author":"Ortega","year":"2005","journal-title":"Ann Hematol"},{"key":"R17-14-20210227","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1086\/425612","article-title":"Prevention of peritransplantation viridans streptococcal bacteremia with early vancomycin administration: a single-center observational cohort study.","volume":"39","author":"Jaffe","year":"2004","journal-title":"Clin Infect Dis"},{"key":"R18-14-20210227","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1046\/j.1365-2141.2002.03457.x","article-title":"Early and late invasive pneumococcal infection following stem cell transplantation: a European Bone Marrow Transplantation survey.","volume":"117","author":"Engelhard","year":"2002","journal-title":"Br J Haematol"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0b013e3182677f35","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T04:13:12Z","timestamp":1620965592000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00043426-201301000-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0b013e3182677f35","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}